Table 2

Demographics of DTI FA clusters

Clustering groupsCluster 1Cluster 2Cluster 3Cluster 4
Characteristics
N, N (%)186 (45.50%)63 (15.50%)74 (18.00%)87 (21.00%)
Males, N (%)107 (57.50%)38 (60.30%)36 (48.60%)50 (57.50%)
Age, median (mad)73.0 (10.80)70.3 (9.60)75.8 (7.30)69.4 (8.00)
Education years and median (mad)16 (3.00)16 (3.00)14 (3.00)14 (3.00)
APOE4 allele carrier, N (%)56 (30.10%)17 (27.00%)20 (27.00%)28 (32.20%)
APOE2 allele carrier, N (%)30 (16.10%)8 (12.70%)15 (20.30%)11 (12.60%)
Health and mean (SD)2.10 (0.80)2.40 (0.80)2.20 (0.90)2.40 (1.00)
Baseline_CMC, mean (SD)2.00 (1.40)2.20 (1.40)2.10 (1.50)2.20 (1.50)
Gait speed, median (mad)113.7 (17.00)116.30 (17.00)111.45 (22.00)113.30 (17.50)
WMH/TIV × 1000.55* (0.04**)0.78 (0.07**)0.83* (0.10**)1.15 (0.10**)
Amyloid load (PiB SUVR)1.42** (0.02**)1.41 (0.02)1.42 (0.03)1.40 (0.03)
Clustering groupsCluster 1Cluster 2Cluster 3Cluster 4
Characteristics
N, N (%)186 (45.50%)63 (15.50%)74 (18.00%)87 (21.00%)
Males, N (%)107 (57.50%)38 (60.30%)36 (48.60%)50 (57.50%)
Age, median (mad)73.0 (10.80)70.3 (9.60)75.8 (7.30)69.4 (8.00)
Education years and median (mad)16 (3.00)16 (3.00)14 (3.00)14 (3.00)
APOE4 allele carrier, N (%)56 (30.10%)17 (27.00%)20 (27.00%)28 (32.20%)
APOE2 allele carrier, N (%)30 (16.10%)8 (12.70%)15 (20.30%)11 (12.60%)
Health and mean (SD)2.10 (0.80)2.40 (0.80)2.20 (0.90)2.40 (1.00)
Baseline_CMC, mean (SD)2.00 (1.40)2.20 (1.40)2.10 (1.50)2.20 (1.50)
Gait speed, median (mad)113.7 (17.00)116.30 (17.00)111.45 (22.00)113.30 (17.50)
WMH/TIV × 1000.55* (0.04**)0.78 (0.07**)0.83* (0.10**)1.15 (0.10**)
Amyloid load (PiB SUVR)1.42** (0.02**)1.41 (0.02)1.42 (0.03)1.40 (0.03)
Diagnosis and cognition
CU, N (%)168 (90.30%)
53 (84.10%)
66 (89.20%)
71 (81.60%)
CU
MCI
CU
MCI
CU
MCI
CU
MCI
MaleFemaleMaleFemaleMaleFemaleMaleFemaleMaleFemaleMaleFemaleMaleFemaleMaleFemale
 Global0.75 (−0.04)0.54* (−0.01)0.31 (−0.04)0.08 (−0.05)0.25 (−0.04)1.01 (−0.03)−0.07 (−0.06)2.18 (−0.09)0.58 (−0.03)1.1 (−0.06)3.96** (−0.28**)0.34 (−0.06)0.29 (−0.04)0.18 (−0.03)−0.26 (−0.04)0.89 (−0.1)
 Memory0.67 (−0.03)0.49* (0)−0.53 (−0.02)0.41 (−0.09)−0.07** (−0.03)1.17 (−0.03)−0.52 (−0.04)2.62 (−0.15)0.43 (−0.02)1.4 (−0.05)2.42** (−0.21**)−0.57 (0.01**)0.09 (−0.01)0.23 (−0.01)−0.65 (0)0.77 (−0.06)
 Executive0.62 (−0.05)0.82* (−0.03*)0.51 (−0.07)−0.48 (0.01)0.37 (−0.05)0.93 (−0.05)0.29 (−0.07)0.57 (0)0.42 (−0.03)1.22 (−0.08)3.66 (−0.26)−0.14 (−0.07)0.5 (−0.07)0.64 (−0.07)0.05 (−0.09)1.19** (−0.15)
 Language0.65 (−0.04**)0.3 (0)0.33 (−0.04**)0.79 (−0.12**)−0.08** (−0.02)0.84 (−0.04)−0.33** (−0.03)3.91 (−0.17)0.14 (−0.01)0.7 (−0.03)2.13 (−0.16**)0.05 (−0.04)0.19 (−0.04)−0.08 (−0.02)−0.84 (−0.01)0.44 (−0.09)
 Visuospatial0.62 (−0.02)0.34 (−0.01)0.3 (−0.02)−0.73 (0.02)0.6 (−0.03)0.49 (−0.01)0.38 (−0.04)0.11 (0)0.72 (−0.02)0.41 (−0.02)3.56 (−0.21)0.36 (−0.05)0.29 (−0.01)−0.1 (−0.01)−0.19 (0.01)0.27 (−0.04)
Diagnosis and cognition
CU, N (%)168 (90.30%)
53 (84.10%)
66 (89.20%)
71 (81.60%)
CU
MCI
CU
MCI
CU
MCI
CU
MCI
MaleFemaleMaleFemaleMaleFemaleMaleFemaleMaleFemaleMaleFemaleMaleFemaleMaleFemale
 Global0.75 (−0.04)0.54* (−0.01)0.31 (−0.04)0.08 (−0.05)0.25 (−0.04)1.01 (−0.03)−0.07 (−0.06)2.18 (−0.09)0.58 (−0.03)1.1 (−0.06)3.96** (−0.28**)0.34 (−0.06)0.29 (−0.04)0.18 (−0.03)−0.26 (−0.04)0.89 (−0.1)
 Memory0.67 (−0.03)0.49* (0)−0.53 (−0.02)0.41 (−0.09)−0.07** (−0.03)1.17 (−0.03)−0.52 (−0.04)2.62 (−0.15)0.43 (−0.02)1.4 (−0.05)2.42** (−0.21**)−0.57 (0.01**)0.09 (−0.01)0.23 (−0.01)−0.65 (0)0.77 (−0.06)
 Executive0.62 (−0.05)0.82* (−0.03*)0.51 (−0.07)−0.48 (0.01)0.37 (−0.05)0.93 (−0.05)0.29 (−0.07)0.57 (0)0.42 (−0.03)1.22 (−0.08)3.66 (−0.26)−0.14 (−0.07)0.5 (−0.07)0.64 (−0.07)0.05 (−0.09)1.19** (−0.15)
 Language0.65 (−0.04**)0.3 (0)0.33 (−0.04**)0.79 (−0.12**)−0.08** (−0.02)0.84 (−0.04)−0.33** (−0.03)3.91 (−0.17)0.14 (−0.01)0.7 (−0.03)2.13 (−0.16**)0.05 (−0.04)0.19 (−0.04)−0.08 (−0.02)−0.84 (−0.01)0.44 (−0.09)
 Visuospatial0.62 (−0.02)0.34 (−0.01)0.3 (−0.02)−0.73 (0.02)0.6 (−0.03)0.49 (−0.01)0.38 (−0.04)0.11 (0)0.72 (−0.02)0.41 (−0.02)3.56 (−0.21)0.36 (−0.05)0.29 (−0.01)−0.1 (−0.01)−0.19 (0.01)0.27 (−0.04)

Main demographic, clinical and biomarker characteristics of the data set (Table 1). The percentages of the clusters sum to 74% of the sample, since a 26% (143 participants) have uncertain classification to any of the clusters (Spplementary Table 1). Health, how healthy the participant feels from 0 to 4 with 4 being worst; CMC, cardiovascular and metabolic conditions; CU, cognitively unimpaired; WMH/TIV × 100 (WMH in FLAIR MRI as a fraction of total intracranial volume; amyloid load, PiB SUVR-Pittsburgh compound B (PiB) PET SUVR] and mad, median absolute deviation. The four domains and their average refer to cognitive functionality, they are Z-values and higher is better cognitive score. For WMH/TIV × 100, amyloid load and the cognitive variables (Global, Memory, Executive, Language and Visuospatial), the data is presented as: estimated fitted value at the 60 years of age (estimated annual change after the age of 60 years). The values are estimated with mixed-effect models: Cluster 1 is the reference group for the models of WMH and PIB (reference group for the cognitive models are cluster 1, CU and female), single asterisk (*) signifies significant difference from 0 in intercept or slope of the reference group, whereas double asterisks (**) signify that a group is significantly different from the reference group in intercept or slope (all tests have a 0.05 confidence level and are corrected with the Satterthwaite’s method and corrected for multiple comparisons with the Holm–Šidák method).

Table 2

Demographics of DTI FA clusters

Clustering groupsCluster 1Cluster 2Cluster 3Cluster 4
Characteristics
N, N (%)186 (45.50%)63 (15.50%)74 (18.00%)87 (21.00%)
Males, N (%)107 (57.50%)38 (60.30%)36 (48.60%)50 (57.50%)
Age, median (mad)73.0 (10.80)70.3 (9.60)75.8 (7.30)69.4 (8.00)
Education years and median (mad)16 (3.00)16 (3.00)14 (3.00)14 (3.00)
APOE4 allele carrier, N (%)56 (30.10%)17 (27.00%)20 (27.00%)28 (32.20%)
APOE2 allele carrier, N (%)30 (16.10%)8 (12.70%)15 (20.30%)11 (12.60%)
Health and mean (SD)2.10 (0.80)2.40 (0.80)2.20 (0.90)2.40 (1.00)
Baseline_CMC, mean (SD)2.00 (1.40)2.20 (1.40)2.10 (1.50)2.20 (1.50)
Gait speed, median (mad)113.7 (17.00)116.30 (17.00)111.45 (22.00)113.30 (17.50)
WMH/TIV × 1000.55* (0.04**)0.78 (0.07**)0.83* (0.10**)1.15 (0.10**)
Amyloid load (PiB SUVR)1.42** (0.02**)1.41 (0.02)1.42 (0.03)1.40 (0.03)
Clustering groupsCluster 1Cluster 2Cluster 3Cluster 4
Characteristics
N, N (%)186 (45.50%)63 (15.50%)74 (18.00%)87 (21.00%)
Males, N (%)107 (57.50%)38 (60.30%)36 (48.60%)50 (57.50%)
Age, median (mad)73.0 (10.80)70.3 (9.60)75.8 (7.30)69.4 (8.00)
Education years and median (mad)16 (3.00)16 (3.00)14 (3.00)14 (3.00)
APOE4 allele carrier, N (%)56 (30.10%)17 (27.00%)20 (27.00%)28 (32.20%)
APOE2 allele carrier, N (%)30 (16.10%)8 (12.70%)15 (20.30%)11 (12.60%)
Health and mean (SD)2.10 (0.80)2.40 (0.80)2.20 (0.90)2.40 (1.00)
Baseline_CMC, mean (SD)2.00 (1.40)2.20 (1.40)2.10 (1.50)2.20 (1.50)
Gait speed, median (mad)113.7 (17.00)116.30 (17.00)111.45 (22.00)113.30 (17.50)
WMH/TIV × 1000.55* (0.04**)0.78 (0.07**)0.83* (0.10**)1.15 (0.10**)
Amyloid load (PiB SUVR)1.42** (0.02**)1.41 (0.02)1.42 (0.03)1.40 (0.03)
Diagnosis and cognition
CU, N (%)168 (90.30%)
53 (84.10%)
66 (89.20%)
71 (81.60%)
CU
MCI
CU
MCI
CU
MCI
CU
MCI
MaleFemaleMaleFemaleMaleFemaleMaleFemaleMaleFemaleMaleFemaleMaleFemaleMaleFemale
 Global0.75 (−0.04)0.54* (−0.01)0.31 (−0.04)0.08 (−0.05)0.25 (−0.04)1.01 (−0.03)−0.07 (−0.06)2.18 (−0.09)0.58 (−0.03)1.1 (−0.06)3.96** (−0.28**)0.34 (−0.06)0.29 (−0.04)0.18 (−0.03)−0.26 (−0.04)0.89 (−0.1)
 Memory0.67 (−0.03)0.49* (0)−0.53 (−0.02)0.41 (−0.09)−0.07** (−0.03)1.17 (−0.03)−0.52 (−0.04)2.62 (−0.15)0.43 (−0.02)1.4 (−0.05)2.42** (−0.21**)−0.57 (0.01**)0.09 (−0.01)0.23 (−0.01)−0.65 (0)0.77 (−0.06)
 Executive0.62 (−0.05)0.82* (−0.03*)0.51 (−0.07)−0.48 (0.01)0.37 (−0.05)0.93 (−0.05)0.29 (−0.07)0.57 (0)0.42 (−0.03)1.22 (−0.08)3.66 (−0.26)−0.14 (−0.07)0.5 (−0.07)0.64 (−0.07)0.05 (−0.09)1.19** (−0.15)
 Language0.65 (−0.04**)0.3 (0)0.33 (−0.04**)0.79 (−0.12**)−0.08** (−0.02)0.84 (−0.04)−0.33** (−0.03)3.91 (−0.17)0.14 (−0.01)0.7 (−0.03)2.13 (−0.16**)0.05 (−0.04)0.19 (−0.04)−0.08 (−0.02)−0.84 (−0.01)0.44 (−0.09)
 Visuospatial0.62 (−0.02)0.34 (−0.01)0.3 (−0.02)−0.73 (0.02)0.6 (−0.03)0.49 (−0.01)0.38 (−0.04)0.11 (0)0.72 (−0.02)0.41 (−0.02)3.56 (−0.21)0.36 (−0.05)0.29 (−0.01)−0.1 (−0.01)−0.19 (0.01)0.27 (−0.04)
Diagnosis and cognition
CU, N (%)168 (90.30%)
53 (84.10%)
66 (89.20%)
71 (81.60%)
CU
MCI
CU
MCI
CU
MCI
CU
MCI
MaleFemaleMaleFemaleMaleFemaleMaleFemaleMaleFemaleMaleFemaleMaleFemaleMaleFemale
 Global0.75 (−0.04)0.54* (−0.01)0.31 (−0.04)0.08 (−0.05)0.25 (−0.04)1.01 (−0.03)−0.07 (−0.06)2.18 (−0.09)0.58 (−0.03)1.1 (−0.06)3.96** (−0.28**)0.34 (−0.06)0.29 (−0.04)0.18 (−0.03)−0.26 (−0.04)0.89 (−0.1)
 Memory0.67 (−0.03)0.49* (0)−0.53 (−0.02)0.41 (−0.09)−0.07** (−0.03)1.17 (−0.03)−0.52 (−0.04)2.62 (−0.15)0.43 (−0.02)1.4 (−0.05)2.42** (−0.21**)−0.57 (0.01**)0.09 (−0.01)0.23 (−0.01)−0.65 (0)0.77 (−0.06)
 Executive0.62 (−0.05)0.82* (−0.03*)0.51 (−0.07)−0.48 (0.01)0.37 (−0.05)0.93 (−0.05)0.29 (−0.07)0.57 (0)0.42 (−0.03)1.22 (−0.08)3.66 (−0.26)−0.14 (−0.07)0.5 (−0.07)0.64 (−0.07)0.05 (−0.09)1.19** (−0.15)
 Language0.65 (−0.04**)0.3 (0)0.33 (−0.04**)0.79 (−0.12**)−0.08** (−0.02)0.84 (−0.04)−0.33** (−0.03)3.91 (−0.17)0.14 (−0.01)0.7 (−0.03)2.13 (−0.16**)0.05 (−0.04)0.19 (−0.04)−0.08 (−0.02)−0.84 (−0.01)0.44 (−0.09)
 Visuospatial0.62 (−0.02)0.34 (−0.01)0.3 (−0.02)−0.73 (0.02)0.6 (−0.03)0.49 (−0.01)0.38 (−0.04)0.11 (0)0.72 (−0.02)0.41 (−0.02)3.56 (−0.21)0.36 (−0.05)0.29 (−0.01)−0.1 (−0.01)−0.19 (0.01)0.27 (−0.04)

Main demographic, clinical and biomarker characteristics of the data set (Table 1). The percentages of the clusters sum to 74% of the sample, since a 26% (143 participants) have uncertain classification to any of the clusters (Spplementary Table 1). Health, how healthy the participant feels from 0 to 4 with 4 being worst; CMC, cardiovascular and metabolic conditions; CU, cognitively unimpaired; WMH/TIV × 100 (WMH in FLAIR MRI as a fraction of total intracranial volume; amyloid load, PiB SUVR-Pittsburgh compound B (PiB) PET SUVR] and mad, median absolute deviation. The four domains and their average refer to cognitive functionality, they are Z-values and higher is better cognitive score. For WMH/TIV × 100, amyloid load and the cognitive variables (Global, Memory, Executive, Language and Visuospatial), the data is presented as: estimated fitted value at the 60 years of age (estimated annual change after the age of 60 years). The values are estimated with mixed-effect models: Cluster 1 is the reference group for the models of WMH and PIB (reference group for the cognitive models are cluster 1, CU and female), single asterisk (*) signifies significant difference from 0 in intercept or slope of the reference group, whereas double asterisks (**) signify that a group is significantly different from the reference group in intercept or slope (all tests have a 0.05 confidence level and are corrected with the Satterthwaite’s method and corrected for multiple comparisons with the Holm–Šidák method).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close